Read More HealthFeed Mar 13, 2023 Medication Questions You Should Be Asking More than half of Americans take at least one prescription medication, and too many are taking pills that they know far too little about
Read More The US Food and Drug Administration has approved Novo Nordisks once-daily weight-loss pill, making it the first oral glucagon-like peptide 1 (GLP-1) product available for weight management
For there to be cost-effectiveness in saving money on claims related to cardiovascular disease, these drugs for weight loss should be priced at $7,500 to $9,800 annually
A single accidental overdose is unlikely to be dangerous but will likely cause more severe nausea, vomiting, and possibly diarrhea
Standard semaglutide titration: Weeks 1-4: 0.25 mg weekly Weeks 5-8: 0.5 mg weekly Weeks 9-12: 1.0 mg weekly Week 13+: 1.7 mg or 2.4 mg weekly (target dose) Hashimoto's-adjusted approach: Weeks 1-6: 0.25 mg weekly (extended to allow thyroid monitoring at week 6) Weeks 7-12: 0.5 mg weekly (TSH check before increasing) Weeks 13-16: 1.0 mg weekly Week 17+: Assess whether higher doses are needed The extended timeline allows for thyroid function checks at each step, ensuring levothyroxine doses are adjusted proactively rather than reactively
Semaglutide belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists